Logo Unión Europea

Development of therapies directed at different therapeutic targets and combined treatments

R&D Project NEOGALFARM

New drugs against cancer: Development of therapies directed at different therapeutic targets and of combined treatments.

GalChimia is part of the Neogalfarm project. Its objective is the identification of new treatments for oncology, using new therapeutic targets as well as combined therapies. The project emerged from a collaboration between AMSlab, NANOGAP, Oncostellae, and several research groups from the University of Santiago de Compostela (USC), the Health Research Institute of Santiago de Compostela (IDIS), and LEITAT.

This project was granted by the Innovation Galician Agency (GAIN) through the Conecta Pyme Program, co-financed by the European Regional Development Fund (ERDF) and supported by the Consellería de Economía, Emprego e Industria (Xunta de Galicia). The total budget is 1,076,339.63 euros.

feder
Logo Xunta de Galicia
gain
Logo Galchimia letters

Subscribe to stay updated on the latest advances in organic synthesis and GalChimia’s good chemistry

     "*" mandatory

    I agree, and accept the data protection policy